Krishnaswamy Yeleswaram, Chief Development Officer: Rapport Therapeutics RAPP Sell · Filed 04/21

Trade details

Type: Insider sale
Amount: $808,797.75
Shares · price: 20,225 sh · $39.99 a share
Held after: 246,426 sh
Stock: Rapport Therapeutics RAPP
Person: Krishnaswamy YeleswaramChief Development Officer
Trade date: 26/04/17
Filed: 26/04/21
Days to filing: 4 days

Sold 7.6% of holdings

Share of holding sold: 7.6%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 03/18~05/17

Krishnaswamy Yeleswaram's recent trades

Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$1.8M
37,000 sh
$1.8M
Filed 08/25
Traded 08/25
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$553.4K
11,472 sh
$553.4K
Filed 08/24
Traded 08/24
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$102.5K
2,092 sh
$102.5K
Filed 08/19
Traded 08/19
Krishnaswamy YeleswaramChief Development Officer
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$799.7K
20,225 sh
$799.7K
Filed 04/17
Traded 04/17
Krishnaswamy YeleswaramChief Development Officer
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$357.8K
10,200 sh
$357.8K
Filed 04/14
Traded 04/14